Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids

ClinicalTrials.gov ID: NCT00006412

Public ClinicalTrials.gov record NCT00006412. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 9, 2026, 7:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter, Randomized Trial Comparing the Efficacy and Safety of Fenofibrate Versus Pravastatin in HIV-Infected Subjects With Lipid Abnormalities

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety and effectiveness of fenofibrate and pravastatin in treating HIV-positive patients who have abnormal levels of fat (lipids) in the blood. Increased lipids in the blood associated with HIV infection and anti-HIV drugs is a growing problem. The drugs used in this study are known to reduce certain lipids, but little is known about their safety and effectiveness. This study will see if one of the drugs is safer and more effective than the other, or if combining the drugs is the safest and most effective way to lower lipids. This study has been changed. On June 26, 2001, this study was reviewed by the Data and Safety Monitoring Board (DSMB). The DSMB is an independent board monitoring the progress of the study. The review showed that neither pravastatin nor fenofibrate alone were effective in reaching all the cholesterol and triglyceride goals. There were no safety concerns. It is not known if the combination of fenofibrate and pravastatin is effective and safe. Therefore, it is important to continue this study.

Study identification

NCT ID
NCT00006412
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
630 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Apr 30, 2003
Last update posted
Oct 31, 2021

Ends 2003

United States locations

U.S. sites
57
U.S. states
21
U.S. cities
36
Facility City State ZIP Site status
Univ of Alabama at Birmingham Birmingham Alabama 35294
Univ of Southern California / LA County USC Med Ctr Los Angeles California 900331079
UCLA CARE Ctr Los Angeles California 90095
Willow Clinic Menlo Park California 94025
Univ of California, San Diego San Diego California 92103
University of California San Francisco San Francisco California 941104206
Univ of California San Francisco San Francisco California 94110
San Mateo AIDS Program / Stanford Univ Stanford California 943055107
Stanford Univ Med Ctr Stanford California 943055107
Harbor UCLA Med Ctr Torrance California 90502
Denver Dept of Health and Hosps Denver Colorado 80262
Univ of Colorado Health Sciences Ctr Denver Colorado 80262
Univ of Miami School of Medicine Miami Florida 331361013
Emory Univ Atlanta Georgia 30308
Univ of Hawaii Honolulu Hawaii 96816
Tripler Army Med Ctr Tripler AMC Hawaii 96859
Northwestern Univ Med School Chicago Illinois 60611
The CORE Ctr Chicago Illinois 60612
Indiana Univ Hosp Indianapolis Indiana 462025250
Methodist Hosp of Indiana / Life Care Clinic Indianapolis Indiana 46202
Wishard Hosp Indianapolis Indiana 46202
Johns Hopkins Hosp Baltimore Maryland 21287
Harvard (Massachusetts Gen Hosp) Boston Massachusetts 02114
Boston Med Ctr Boston Massachusetts 02118
Beth Israel Deaconess - West Campus Boston Massachusetts 02215
Brigham and Women's Hosp Boston Massachusetts 02215
Univ of Minnesota Minneapolis Minnesota 55455
Univ of Nebraska Med Ctr Omaha Nebraska 681985130
SUNY / Erie County Med Ctr at Buffalo Buffalo New York 14215
Beth Israel Med Ctr New York New York 10003
Cornell Clinical Trials Unit - Chelsea Clinic New York New York 10011
Bellevue Hosp / New York Univ Med Ctr New York New York 10016
Cornell Univ Med Ctr New York New York 10021
Mount Sinai Med Ctr New York New York 10029
Columbia Presbyterian Med Ctr New York New York 10032
Community Health Network Inc Rochester New York 14642
St Mary's Hosp (Univ of Rochester/Infectious Diseases) Rochester New York 14642
Univ of Rochester Medical Center Rochester New York 14642
Univ of North Carolina Chapel Hill North Carolina 275997215
Carolinas Med Ctr Charlotte North Carolina 28203
Duke Univ Med Ctr Durham North Carolina 27710
Moses H Cone Memorial Hosp Greensboro North Carolina 27401
Univ of Cincinnati Cincinnati Ohio 452670405
Case Western Reserve Univ Cleveland Ohio 44106
MetroHealth Med Ctr Cleveland Ohio 441091998
Ohio State Univ Hosp Clinic Columbus Ohio 432101228
Philadelphia Veterans Administration Med Ctr Philadelphia Pennsylvania 19104
Univ of Pennsylvania Philadelphia Pennsylvania 19104
Univ of Pittsburgh Pittsburgh Pennsylvania 15213
Rhode Island Hosp / Brown Univ Providence Rhode Island 02903
Brown Univ / Miriam Hosp Providence Rhode Island 02906
Miriam Hosp / Brown Univ Providence Rhode Island 02906
Julio Arroyo West Columbia South Carolina 29169
Vanderbilt Univ Med Ctr Nashville Tennessee 37203
Univ of Texas, Southwestern Med Ctr of Dallas Dallas Texas 75390
Univ of Texas Galveston Galveston Texas 775550435
Univ of Washington Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006412, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced Sep 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00006412 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →